Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10316/112596
Campo DC | Valor | Idioma |
---|---|---|
dc.contributor.author | Zimmermannova, Olga | - |
dc.contributor.author | Ferreira, Alexandra G. | - |
dc.contributor.author | Ascic, Ervin | - |
dc.contributor.author | Velasco Santiago, Marta | - |
dc.contributor.author | Kurochkin, Ilia | - |
dc.contributor.author | Hansen, Morten | - |
dc.contributor.author | Met, Özcan | - |
dc.contributor.author | Caiado, Inês | - |
dc.contributor.author | Shapiro, Ilja E. | - |
dc.contributor.author | Michaux, Justine | - |
dc.contributor.author | Humbert, Marion | - |
dc.contributor.author | Soto-Cabrera, Diego | - |
dc.contributor.author | Benonisson, Hreinn | - |
dc.contributor.author | Silvério-Alves, Rita | - |
dc.contributor.author | Gomez-Jimenez, David | - |
dc.contributor.author | Bernardo, Carina | - |
dc.contributor.author | Bauden, Monika | - |
dc.contributor.author | Andersson, Roland | - |
dc.contributor.author | Höglund, Mattias | - |
dc.contributor.author | Miharada, Kenichi | - |
dc.contributor.author | Nakamura, Yukio | - |
dc.contributor.author | Hugues, Stephanie | - |
dc.contributor.author | Greiff, Lennart | - |
dc.contributor.author | Lindstedt, Malin | - |
dc.contributor.author | Rosa, Fábio F. | - |
dc.contributor.author | Pires, Cristiana F. | - |
dc.contributor.author | Bassani-Sternberg, Michal | - |
dc.contributor.author | Svane, Inge Marie | - |
dc.contributor.author | Pereira, Carlos Filipe | - |
dc.date.accessioned | 2024-02-01T13:08:37Z | - |
dc.date.available | 2024-02-01T13:08:37Z | - |
dc.date.issued | 2023-07-14 | - |
dc.identifier.issn | 2470-9468 | pt |
dc.identifier.uri | https://hdl.handle.net/10316/112596 | - |
dc.description.abstract | Decreased antigen presentation contributes to the ability of cancer cells to evade the immune system. We used the minimal gene regulatory network of type 1 conventional dendritic cells (cDC1) to reprogram cancer cells into professional antigen-presenting cells (tumor-APCs). Enforced expression of the transcription factors PU.1, IRF8, and BATF3 (PIB) was sufficient to induce the cDC1 phenotype in 36 cell lines derived from human and mouse hematological and solid tumors. Within 9 days of reprogramming, tumor-APCs acquired transcriptional and epigenetic programs associated with cDC1 cells. Reprogramming restored the expression of antigen presentation complexes and costimulatory molecules on the surfaces of tumor cells, allowing the presentation of endogenous tumor antigens on MHC-I and facilitating targeted killing by CD8+ T cells. Functionally, tumor-APCs engulfed and processed proteins and dead cells, secreted inflammatory cytokines, and cross-presented antigens to naïve CD8+ T cells. Human primary tumor cells could also be reprogrammed to increase their capability to present antigen and to activate patient-specific tumor-infiltrating lymphocytes. In addition to acquiring improved antigen presentation, tumor-APCs had impaired tumorigenicity in vitro and in vivo. Injection of in vitro generated melanoma-derived tumor-APCs into subcutaneous melanoma tumors delayed tumor growth and increased survival in mice. Antitumor immunity elicited by tumor-APCs was synergistic with immune checkpoint inhibitors. Our approach serves as a platform for the development of immunotherapies that endow cancer cells with the capability to process and present endogenous tumor antigens. | pt |
dc.language.iso | eng | pt |
dc.publisher | American Association for the Advancement of Science | pt |
dc.rights | openAccess | pt |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt |
dc.subject.mesh | Humans | pt |
dc.subject.mesh | Mice | pt |
dc.subject.mesh | Animals | pt |
dc.subject.mesh | Cellular Reprogramming | pt |
dc.subject.mesh | Dendritic Cells | pt |
dc.subject.mesh | Antigens, Neoplasm | pt |
dc.subject.mesh | CD8-Positive T-Lymphocytes | pt |
dc.subject.mesh | Melanoma | pt |
dc.title | Restoring tumor immunogenicity with dendritic cell reprogramming | pt |
dc.type | article | - |
degois.publication.firstPage | eadd4817 | pt |
degois.publication.issue | 85 | pt |
degois.publication.title | Science Immunology | pt |
dc.peerreviewed | yes | pt |
dc.identifier.doi | 10.1126/sciimmunol.add4817 | pt |
degois.publication.volume | 8 | pt |
dc.date.embargo | 2023-07-14 | * |
uc.date.periodoEmbargo | 0 | pt |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | open | - |
item.openairetype | article | - |
item.languageiso639-1 | en | - |
item.fulltext | Com Texto completo | - |
item.cerifentitytype | Publications | - |
crisitem.author.researchunit | CNC - Center for Neuroscience and Cell Biology | - |
crisitem.author.researchunit | CNC - Center for Neuroscience and Cell Biology | - |
crisitem.author.researchunit | CNC - Center for Neuroscience and Cell Biology | - |
crisitem.author.orcid | https://orcid.org/0000-0002-4630-171X | - |
crisitem.author.orcid | 0000-0002-9724-1382 | - |
Aparece nas coleções: | I&D CNC - Artigos em Revistas Internacionais |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
Supplementary materials_Restoring-tumor-immunogenicity-with-dendritic-cell-reprogrammingScience-Immunology.pdf | 18.68 MB | Adobe PDF | Ver/Abrir | |
Restoring tumor immunogenicity with dendritic cell reprogramming.pdf | 4.42 MB | Adobe PDF | Ver/Abrir |
Visualizações de página
69
Visto em 28/ago/2024
Downloads
48
Visto em 28/ago/2024
Google ScholarTM
Verificar
Altmetric
Altmetric
Este registo está protegido por Licença Creative Commons